MassMutual Private Wealth & Trust FSB Has $381,000 Position in Colgate-Palmolive (NYSE:CL)

MassMutual Private Wealth & Trust FSB raised its stake in Colgate-Palmolive (NYSE:CL) by 3.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,187 shares of the company’s stock after buying an additional 133 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Colgate-Palmolive were worth $381,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FMR LLC grew its stake in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares in the last quarter. Barclays PLC lifted its stake in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares during the last quarter. State Street Corp grew its position in Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB increased its stake in shares of Colgate-Palmolive by 32.5% during the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 58.6% during the 2nd quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock valued at $234,540,000 after purchasing an additional 892,706 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.8 %

CL opened at $87.53 on Thursday. Colgate-Palmolive has a fifty-two week low of $80.03 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm’s fifty day moving average price is $92.07 and its two-hundred day moving average price is $97.65. The company has a market capitalization of $71.51 billion, a P/E ratio of 25.08, a P/E/G ratio of 3.64 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CL shares. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. UBS Group decreased their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $101.11.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.37% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.